AT-Patch (ATP-C130/ATP-C70) vs Caption Guidance
AI Verdict
Choose AT-Patch (ATP-C130/ATP-C70) if…
Choose AT-Patch if you require continuous, long-term (up to 14 days) ambulatory ECG monitoring for patients suspected of intermittent arrhythmias or for post-treatment evaluation. Its lightweight, shower-proof design and integrated AI analysis are ideal for comfortable, accurate data collection outside of a clinical setting, minimizing motion artifacts and patient burden.
View AT-Patch (ATP-C130/ATP-C70) →Choose Caption Guidance if…
Choose Caption Guidance if your objective is to empower healthcare providers, including those with less specialized training, to acquire diagnostic-quality cardiac ultrasound images directly at the point of care. This AI-guided software provides real-time feedback on probe manipulation and image quality, significantly enhancing access to critical cardiac diagnostics and improving consistency in ultrasound acquisition.
View Caption Guidance →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AT-Patch (ATP-C130/ATP-C70) | Caption Guidance |
|---|---|---|
| Deployment | Wearable device for patients; analysis software deployed on-premise at medical institutions. | On-premise (integrated with ultrasound equipment) and cloud-based services. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AT-Patch (ATP-C130/ATP-C70)AT-Patch prioritizes patient comfort and ease of use with its compact, lightweight, shower-proof design, and no need for charging or electrode replacement during up to 14 days of monitoring. The AT-Note smartphone app further enhances patient engagement for live ECG viewing and symptom recording.
Clinical Value
Caption GuidanceCaption Guidance offers transformative clinical value by democratizing access to diagnostic-quality cardiac ultrasound, enabling a wider range of healthcare providers to perform complex imaging with real-time AI guidance. This significantly enhances early diagnosis and access to critical cardiac diagnostics.
Pricing & Value
TieNeither tool provides publicly available enterprise pricing, making a direct comparison of value difficult. While Tool B mentions a subscription model and an introductory price for a direct-to-patient service, this does not offer sufficient detail for enterprise-level cost assessment.
Enterprise Readiness
Caption GuidanceCaption Guidance explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for enterprise adoption. Its integration with existing GE HealthCare ultrasound systems and being part of GE HealthCare further solidifies its enterprise readiness and support infrastructure.
Innovation
Caption GuidanceCaption Guidance represents a more disruptive innovation by enabling non-expert clinicians to acquire diagnostic-quality cardiac ultrasound images through real-time AI guidance. This fundamentally changes who can perform these complex diagnostic procedures, expanding access to care.
Support & Docs
Caption GuidanceAs part of GE HealthCare, Caption Guidance benefits from an extensive, well-established global support network and comprehensive documentation, including operator manuals accessible within the software. While AT-Patch offers standard user manuals and contact support, GE HealthCare's infrastructure provides a more robust and scalable support system.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AT-Patch (ATP-C130/ATP-C70) | Caption Guidance |
|---|---|---|
| Tool Name | AT-Patch (ATP-C130/ATP-C70) | Caption Guidance |
| Primary Function | FDA-cleared wearable ECG monitor offering up to 14 days of continuous cardiac monitoring with high accuracy, a shower-proof design, and integrated AI-powered analysis software for enhanced arrhythmia detection. | First FDA-cleared AI-guided software that empowers healthcare providers to acquire diagnostic-quality cardiac ultrasound images with real-time guidance and automated quality assessment, enhancing access to critical cardiac diagnostics. |
| Company | ATsens Co. | Caption Health (now part of GE HealthCare) |
| Key AI Application | AT-Report software with AI/machine learning algorithms for ECG analysis | Real-time AI guidance for ultrasound probe manipulation; Automated quality assessment with a 'Quality Meter' |
| Specialties Supported | Cardiology, Family Medicine, Internal Medicine | Cardiology, Critical Care, Radiology |
| Monitoring/Guidance Type & Duration | Up to 14 days of continuous ECG monitoring (ATP-C130) | Real-time AI guidance during ultrasound image acquisition |
Videos
Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and Caption Guidance.